Sudarshan Chemical Industries (506655) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
1 Oct, 2026Executive summary
Completed integration of Clariant and Heubach, creating a global pigment leader with 19 manufacturing sites across 11 countries and over 4,000 customers, and maintained global leadership in pigments with a robust product portfolio.
Achieved strong profitability momentum in Q1 FY27, with significant improvements in EBITDA and net debt reduction compared to previous periods.
Established a unified culture, filled leadership gaps, and set up a second global headquarters in Frankfurt, with SAP implementation underway.
Unaudited standalone and consolidated financial results for the quarter ended 30th June 2026 were approved, showing strong revenue and profit growth year-over-year.
In-principle approval was granted for internal restructuring via acquisition of a 70.26% stake in a step-down subsidiary, Sudarshan Colorants India Limited, to be held directly.
Financial highlights
Q1 FY27 consolidated revenue from operations was ₹2,642.1 crore, up 5.4% year-over-year; business EBITDA reached ₹247 crore, reported EBITDA was ₹266 crore, and consolidated net profit was ₹103.4 crore.
Pigment segment Q1 FY27 revenue was ₹2,604.4 crore, with EBITDA at ₹268.8 crore; acquired group reported EBITDA of ₹146 crore.
Earnings per share for Q1 FY27 was ₹12.3, up from ₹6.0 in Q1 FY26; return on capital employed improved to 22.7%.
Net debt reduced to ₹531 crore, with a net debt/EBITDA ratio of 0.2 and net debt to equity ratio at 0.2.
Standalone revenue from operations for Q1 FY27 was ₹732.7 crore, up from ₹531.2 crore in Q1 FY26.
Outlook and guidance
Maintains FY27 guidance of €700 million revenue and €35 million EBITDA for the acquired group, despite strong Q1 performance.
No revision to guidance due to geopolitical uncertainties; will reassess after Q3.
Focus remains on value capture, cost reduction, and working capital release, with continued integration and synergy capture.
Expects margin improvement for the acquired group to high single digits or low double digits by FY27.
Internal restructuring and integration costs indicate ongoing transformation and focus on operational efficiency.
Latest events from Sudarshan Chemical Industries
- Q1 FY25 saw higher revenue, EBITDA, and margins, with normalized profit and improved leverage.506655
Q1 24/25 - Heubach acquisition adds global scale, with full benefits targeted within two years.506655
M&A announcement - Record pigment sales lifted margins as Heubach acquisition advanced.506655
Q2 24/25 - Q3 FY25 saw strong revenue growth, margin gains, and progress on the Heubach acquisition despite costs.506655
Q3 24/25 - Heubach lifts FY25 sales and adjusted EBITDA, with profitability targets hinging on integration.506655
Q4 24/25 - Q1 FY26 revenue rose to ₹2,507 crore with EBITDA up, but margins and net profit ratio declined.506655
Q1 25/26 - Q2 sales grew despite destocking; Heubach guidance fell as integration advanced.506655
Q2 25/26 - Weak demand drove a consolidated loss, while cost savings and restocking signal recovery.506655
Q3 25/26 - Q4 growth, acquired-group recovery and debt reduction support FY27 plans amid cost risks.506655
Q4 25/26